|
|
 |
|
Viewing report
|
|
 |
 |
Therapeutic Strategies in Lipid Disorders
Clinical Publishing, April 2009, Pages: 296
Lipid disorders are now recognised as a diverse group of diseases that together represent one of the foremost risk factors for cardiovascular disease in general. Frequently present in association with other chronic illnesses such as hypertension, diabetes, and obesity, lipid disorders are a key therapeutic target for clinicians. This book examines the causes and consequences of lipid disorders, and the treatments available. Special chapters are dedicated to the associations between lipid disorders and other conditions, for example cerebrovascular disease and heart failure, as well as the wider applications for lipid-lowering agents in the management of co-morbidities. The book concludes with a review of novel lipid-modifying agents, emerging diagnostic technologies such as intravascular ultrasound, and the use of biomarkers as risk predictors.
Benefits: - Translates scientific evidence into improved clinical outcomes - In-depth discussion of concomitant disorders associated with dyslipidaemia - Synthesizing publication and trial data to enable effective diagnosis and targeted prescribing decisions
Readership:
- Cardiologists - Endocrinologists - Nephrologists - General physicians - Doctors in training
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Nitric Oxide - Therapeutics, Markets and Companies
The Year in Lipid Disorders Volume 2
Molecular Diagnostics - Technologies, Markets and Companies
Clinical Challenges in Lipid Disorders
Therapeutic Strategies in Diabetes
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
Textbook of Diabetes, 4th Edition
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
Biomarkers - Global Strategic Business Report
Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements
|
 |
|
|